Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alexion Reports First Quarter 2013 Results
Yahoo
Thursday, April 25, 2013 - 10:45am
tags:
earnings, Alexion
Valeant completes tender offer for Obagi Medical
Yahoo/Fly on the Wall
Thursday, April 25, 2013 - 10:45am
tags:
Valeant Pharmaceuticals, Obagi Medical Products, M&A
Biogen Idec 1Q income rises on lower tax rate
Yahoo/AP
Thursday, April 25, 2013 - 10:44am
tags:
earnings, Biogen Idec
Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race
Bloomberg
Thursday, April 25, 2013 - 10:43am
tags:
JNJ, patents, Eli Lilly, Alzheimer's disease, solanezumab
In Moribund Cholesterol Field, A New Drug Emerges
Forbes
Thursday, April 25, 2013 - 9:27am
tags:
ETC-1002, Pfizer, Esperion, Merck, Amgen, Sanofi, AstraZeneca
Bristol profit drops sharply, but meets Wall Street forecast
Reuters
Thursday, April 25, 2013 - 9:26am
tags:
earnings, Bristol-Myers Squibb
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
TheStreet.com
Thursday, April 25, 2013 - 9:25am
tags:
Aveo Pharmaceuticals, kidney cancer, FDA, advisory panels, tivozanib
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Thursday, April 25, 2013 - 9:24am
tags:
Sarepta, GSK, eteplirsen, Duchenne Muscular Dystrophy
How Will AbbVie's Earnings Fare?
Motley Fool
Thursday, April 25, 2013 - 9:22am
tags:
AbbVie, earnings
Biotechs Near Highs In A Week Of Key Earnings Reports
Investors.com
Wednesday, April 24, 2013 - 5:23pm
tags:
biotech, earnings, Regeneron, United Therapeutics, Medicines Company
Analyst Favorites With Strong Buyback Activity: ViroPharma Ranks As a Top Pick
Forbes
Wednesday, April 24, 2013 - 4:50pm
tags:
ViroPharma
Will The Big Pharmaceuticals Fall Off A Patent Cliff?
Seeking Alpha
Wednesday, April 24, 2013 - 4:47pm
tags:
patent cliff, patents, GSK, Eli Lilly, AstraZeneca, Merck, Pfizer
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wednesday, April 24, 2013 - 4:46pm
tags:
orphan drugs, Raptor Pharmaceuticals, Aegerion, Juxtapid, procysbi
Glaxo Profit Falls on Divestments as Approvals Awaited
Bloomberg
Wednesday, April 24, 2013 - 10:30am
tags:
earnings, GSK
FDA Discouraging Real-Time Release Testing as a Shortcut to End Testing, Experts Say
in-Pharma Technologist
Wednesday, April 24, 2013 - 10:29am
tags:
R&D
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Wednesday, April 24, 2013 - 10:27am
tags:
Agenus, Aveo Pharmaceuticals, Insmed, GSK, Sarepta
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wednesday, April 24, 2013 - 10:25am
tags:
Arena Pharmaceuticals, Europe, DEA, Eisai, Vivus, Orexigen
OPKO Health To Acquire PROLOR Biotech
Yahoo
Wednesday, April 24, 2013 - 10:24am
tags:
OPKO Health, Prolor Biotech, M&A
Vertex Spikes On Phase II Data, Then The CFO Sells His Shares
Seeking Alpha
Wednesday, April 24, 2013 - 10:23am
tags:
Vertex Pharmaceuticals, VX-661, cystic fibrosis
Amgen 1Q profit up 21 pct on lower taxes, expenses
Yahoo/AP
Wednesday, April 24, 2013 - 10:21am
tags:
earnings, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.